Ipsen acquires Clementia in bid to boost rare disease portfolio

25th February 2019 Uncategorised 0

Ipsen has announced plans to acquire Clementia Pharmaceuticals.

More: Ipsen acquires Clementia in bid to boost rare disease portfolio
Source: News